Because FKBP51 is overexpressed in cancer cells, the oncogene activity of AR is enhanced and the tumour suppressor action of GR results inhibited, which contributes to the bad prognosis related to the expression of this immunophilin in prostate cancer [58,100]. This evidence concerns the gene AR and prostate cancer.